Dongguan Convergence Technology Unveils Medical Part 002 with Advanced 2K Injection Mold Precision

Introduction 

In April 2026, Dongguan Convergence Technology Co. Ltd. (CT) officially launched Medical Part 002, a high-precision medical component designed and manufactured with our proprietary 2K injection mold process. Since founding in March 2013, CT has developed a 3,000 m² science and technology park and integrated R&D, production, sales and service. Medical Part 002 demonstrates CT’s commitment to ISO9001-certified quality, rapid delivery capacity, and customization expertise.

1. Core Specifications of Medical Part 002

• Mold Type: 2K injection mold, 4-cavity design, tool steel S136H

• Material: Medical-grade PC/ABS blend with biocompatibility certification ISO 10993

• Dimensional Tolerance: ±0.01 mm across 50 × 20 × 10 mm part dimensions

• Cycle Time: 30 seconds per shot at 120 ton clamping force

• Annual Capacity: 200,000 units (peak output in 2025)

• Delivery Lead Time: 4–6 weeks from order confirmation

2. Why Medical Part 002 Excels

2.1 Unmatched Precision with 2K injection mold

• Bi-component molding for integrated sealing and rigid structure.

• Dual material gates achieve 0.02 mm concentricity.

• Real-time cavity monitoring reduces scrap rate below 1.5%.

2.2 Multi-Sector Expertise

CT supplies high-quality molds for a broad spectrum of applications. In addition to medical devices, our portfolio includes:

- Automotive injection parts: Engine covers, sensor housings, and interior trims with tolerance ±0.02 mm.

- Sport injection parts: High-impact bicycle pedals and helmet shells tested at 150 J impact energy.

- Industrial injection parts: Gearboxes and valve bodies enduring 10 million cycle fatigue tests.

- Household injection parts: Appliance knobs and kitchenware handles with 5 kg load capacity.

3. Data-Driven Quality Control

• Global Supply Chain Integration: 50+ certified suppliers across Asia and Europe provide premium-grade resins.

• ISO9001 Certification: Passed in 2019 and audited bi-annually, ensuring ≤0.5% defect rate.

• Cost Performance: Large-scale production reduces unit cost by 18% compared to single-cavity molds.

4. Customization Expertise and Selection Advice

When selecting an injection-molded medical part, consider:

a. Material Compliance: Medical Part 002 uses PC/ABS tested for cytotoxicity and sterilization resistance.

b. Mold Complexity: Our 2K injection mold process integrates soft-touch seals with hard structural cores in a single cycle.

c. Batch Volume: For 10,000–100,000 units annually, 4-cavity 2K injection mold yields optimal cost control.

d. Lead Time: CT’s streamlined production achieves 4–6 week delivery, 20% faster than industry average.

5. Rapid Delivery Capacity

• Dedicated 24/7 operation lines enable up to 25 mold changes per day.

• Real-time SAP tracking provides delivery status with 99% on-time performance in 2025.

• Express tooling adjustment service reduces post-molding corrections by 30%.

Conclusion

Medical Part 002 sets a new benchmark for medical-grade injection components. Leveraging CT’s world-leading 2K injection mold technology, high-precision process control, and multi-sector expertise in Automotive injection parts, Sport injection parts, Industrial injection parts, and Household injection parts, customers benefit from exceptional quality, competitive lead times, and cost-efficient production. When precision, reliability, and rapid delivery matter, choose CT’s Medical Part 002.

CONTACT US：

TEL: +86(0)769 89361496

WeChat: +86 13714295799

E-mail: general_manager@ct-tooling.com